The Food and Drug Administration has proposed draft industry guidance to ensure that social media and Internet communications relating to medical products are clear, accurate, truthful, and do not mislead the public.

Concerned that patients and healthcare providers regularly get information about FDA-regulated medical products through social media and other Internet sources, the agency drafted two separate draft guidances with recommendations to help manufacturers accurately communicate online about prescription drugs and medical devices.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access